Strategic Advocates’s Emerson Electric EMR Stock Holding History

Strategic Advocates’s Portfolio EMR Stock Details EMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-536	Closed	-$72.5K	–	365
2025 Q4	$72.5K	Buy	536 +18	+3%	+$2.39K	0.02%	173
2025 Q3	$68K	Buy	+518	New	+$70.6K	0.02%	181

Other funds holding EMR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Strategic Advocates's EMR Position: Q1 2026 in Review

Strategic Advocates sold out of Emerson Electric (EMR) in Q1 2026, closing a stake of 536 shares — an estimated $72.5K sold.

Strategic Advocates first reported a position in EMR in Q3 2025 and held it in 2 quarters. The position peaked at $72.5K in Q4 2025. 2,212 funds tracked by Wall St. Rank hold EMR as of Q1 2026.

Strategic Advocates reported no remaining Emerson Electric position as of Q1 2026 after selling out during the quarter.
Strategic Advocates sold 536 Emerson Electric shares in Q1 2026, an estimated $72.5K.
Strategic Advocates first reported a position in Emerson Electric in Q3 2025 and held it in 2 quarters.
Strategic Advocates's Emerson Electric position peaked at $72.5K in Q4 2025.
2,212 funds tracked by Wall St. Rank held Emerson Electric as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.